FDA Approved: IRBESARTAN — Original Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's original Abbreviated New Drug Application for irbesartan, enabling a generic version of the medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)